Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
Investing.com - BTIG lowered its price target on Alcon Inc. (NYSE:ALC) to $92 from $100 while maintaining a Buy rating following the company’s second-quarter 2025 results. The stock, currently trading at $81.63, is near its 52-week low of $80.48, according to InvestingPro data.
Alcon reported approximately 3.0% currency-neutral growth, with its Surgical segment growing 1.0% and Vision Care segment growing 5.0%. The company posted core earnings per share of $0.76, with gross margins and operating margins exceeding Street expectations by 30 and 20 basis points, respectively. InvestingPro data shows the company maintains a healthy 55.58% gross profit margin, with an overall financial health score rated as "GREAT."
The eye care company reduced its fiscal year 2025 sales growth guidance to 4%-5% currency-neutral from the previous 6%-7%, with overall sales guidance now set at $10.3 billion to $10.4 billion, down from $10.4 billion to $10.5 billion previously. This revised outlook falls below the Street’s expectation of $10.47 billion. For deeper insights into Alcon’s valuation and growth prospects, access the comprehensive Pro Research Report, available exclusively on InvestingPro.
BTIG noted that Alcon has "damaged its credibility" by missing expectations in recent quarters, particularly by incorrectly assuming the broader surgical eye care market would recover in fiscal year 2025. The firm indicated that shares were being "punished" following the announcement.
Despite near-term challenges, BTIG highlighted Alcon’s strong product pipeline for the second half of 2025 and maintained that the long-term fundamentals supporting ophthalmology remain intact, with shares trading at approximately 25.5 times next-twelve-months earnings, "well below ALC’s historical valuation levels."
In other recent news, Alcon AG announced its second-quarter 2025 financial results. The company reported earnings per share (EPS) of $0.76, which exceeded analyst expectations of $0.7194. Despite this positive earnings surprise, Alcon’s revenue for the quarter was $2.58 billion, falling short of the projected $2.63 billion. This revenue miss has raised concerns among investors, even though the EPS surpassed forecasts. The financial figures reflect the latest developments within the company. Alcon’s performance is being closely monitored by investors and analysts alike. The company’s earnings and revenue figures are crucial for understanding its current financial health. Analyst assessments and investor reactions are likely to continue evolving as more information becomes available.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.